324 related articles for article (PubMed ID: 18288984)
1. Pharmacotherapies to manage bone loss-associated diseases: a quest for the perfect benefit-to-risk ratio.
Valverde P
Curr Med Chem; 2008; 15(3):284-304. PubMed ID: 18288984
[TBL] [Abstract][Full Text] [Related]
2. Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review.
Gallacher SJ; Dixon T
Calcif Tissue Int; 2010 Dec; 87(6):469-84. PubMed ID: 20872215
[TBL] [Abstract][Full Text] [Related]
3. Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis.
Lewiecki EM
J Womens Health (Larchmt); 2009 Oct; 18(10):1615-26. PubMed ID: 19857095
[TBL] [Abstract][Full Text] [Related]
4. Drugs for postmenopausal osteoporosis.
Treat Guidel Med Lett; 2008 Oct; 6(74):67-74; quiz 75-6. PubMed ID: 18800025
[No Abstract] [Full Text] [Related]
5. How to manage postmenopausal osteoporosis?
Body JJ
Acta Clin Belg; 2011; 66(6):443-7. PubMed ID: 22338309
[TBL] [Abstract][Full Text] [Related]
6. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
Wensel TM; Iranikhah MM; Wilborn TW
Pharmacotherapy; 2011 May; 31(5):510-23. PubMed ID: 21923432
[TBL] [Abstract][Full Text] [Related]
7. Prescription drug therapies for prevention and treatment of postmenopausal osteoporosis.
O'Connell MB
J Manag Care Pharm; 2006 Jul; 12(6 Suppl A):S10-9; quiz S26-8. PubMed ID: 17269853
[TBL] [Abstract][Full Text] [Related]
8. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
9. [Austrian guidance for the pharmacologic treatment of osteoporosis in postmenopausal women: Addendum 2010].
Dimai HP; Pietschmann P; Resch H; Preisinger E; Fahrleitner-Pammer A; Dobnig H; Klaushofer K;
Wien Med Wochenschr; 2010 Dec; 160(21-22):586-9. PubMed ID: 21170699
[TBL] [Abstract][Full Text] [Related]
10. Individualizing osteoporosis therapy.
Silverman S; Christiansen C
Osteoporos Int; 2012 Mar; 23(3):797-809. PubMed ID: 22218417
[TBL] [Abstract][Full Text] [Related]
11. Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
Cummings SR; San Martin J; McClung MR; Siris ES; Eastell R; Reid IR; Delmas P; Zoog HB; Austin M; Wang A; Kutilek S; Adami S; Zanchetta J; Libanati C; Siddhanti S; Christiansen C;
N Engl J Med; 2009 Aug; 361(8):756-65. PubMed ID: 19671655
[TBL] [Abstract][Full Text] [Related]
12. Denosumab for treatment of postmenopausal osteoporosis.
Chitre M; Shechter D; Grauer A
Am J Health Syst Pharm; 2011 Aug; 68(15):1409-18. PubMed ID: 21785030
[TBL] [Abstract][Full Text] [Related]
13. [Osteoporosis].
Buck G; Perger L; Bischoff-Ferrari HA
Praxis (Bern 1994); 2011 Jul; 100(14):821-32. PubMed ID: 21732293
[No Abstract] [Full Text] [Related]
14. [Innovations in the treatment of osteoporosis].
Tsourdi E; Hofbauer LC
Dtsch Med Wochenschr; 2011 Dec; 136(48):2458-60. PubMed ID: 22109575
[No Abstract] [Full Text] [Related]
15. Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls.
Cremers S; Garnero P
Drugs; 2006; 66(16):2031-58. PubMed ID: 17112299
[TBL] [Abstract][Full Text] [Related]
16. Management of osteoporosis and Paget's disease. An appraisal of the risks and benefits of drug treatment.
Gennari C; Nuti R; Agnusdei D; Camporeale A; Martini G
Drug Saf; 1994 Sep; 11(3):179-95. PubMed ID: 7811400
[TBL] [Abstract][Full Text] [Related]
17. Safety concerns with the long-term management of osteoporosis.
Reginster JY; Pelousse F; Bruyère O
Expert Opin Drug Saf; 2013 Jul; 12(4):507-22. PubMed ID: 23614635
[TBL] [Abstract][Full Text] [Related]
18. Drug-Related Adverse Events of Osteoporosis Therapy.
Khan M; Cheung AM; Khan AA
Endocrinol Metab Clin North Am; 2017 Mar; 46(1):181-192. PubMed ID: 28131131
[TBL] [Abstract][Full Text] [Related]
19. Prevention and treatment of postmenopausal osteoporosis.
Tella SH; Gallagher JC
J Steroid Biochem Mol Biol; 2014 Jul; 142():155-70. PubMed ID: 24176761
[TBL] [Abstract][Full Text] [Related]
20. New developments in the treatment of osteoporosis.
Eriksen EF; Halse J; Moen MH
Acta Obstet Gynecol Scand; 2013 Jun; 92(6):620-36. PubMed ID: 22646526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]